AEGIS’ alliance with a leading European dossier provider, AET Trusted Partner, enabled AEGIS to acquire one of the strongest generic pipelines in the international market. Over a hundred chemical entities with marketing authorizations are included in the product list while submitting for registration about 25 different chemical entities of the latest generics each year.

AEGIS’ priority is to offer first class quality products by meeting or exceeding international specifications in the laboratories, manufacturing and technical facilities. AEGIS strives to offer branded alternative drugs, therapeutically equivalent and interchangeable compared to the products of the industry leaders, at affordable prices.
 

The products are complying with the latest Quality Standards produced at EU GMP facilities employing modern technology.